These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10343605)

  • 1. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?
    Iino H; Jass JR; Simms LA; Young J; Leggett B; Ajioka Y; Watanabe H
    J Clin Pathol; 1999 Jan; 52(1):5-9. PubMed ID: 10343605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum.
    Jass JR; Iino H; Ruszkiewicz A; Painter D; Solomon MJ; Koorey DJ; Cohn D; Furlong KL; Walsh MD; Palazzo J; Edmonston TB; Fishel R; Young J; Leggett BA
    Gut; 2000 Jul; 47(1):43-9. PubMed ID: 10861263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serrated adenoma and colorectal cancer.
    Jass JR
    J Pathol; 1999 Apr; 187(5):499-502. PubMed ID: 10398112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperplastic polyposis: association with colorectal cancer.
    Leggett BA; Devereaux B; Biden K; Searle J; Young J; Jass J
    Am J Surg Pathol; 2001 Feb; 25(2):177-84. PubMed ID: 11176066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.
    Hawkins NJ; Ward RL
    J Natl Cancer Inst; 2001 Sep; 93(17):1307-13. PubMed ID: 11535705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer.
    Iino H; Simms L; Young J; Arnold J; Winship IM; Webb SI; Furlong KL; Leggett B; Jass JR
    Gut; 2000 Jul; 47(1):37-42. PubMed ID: 10861262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma.
    Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Glickman JN; Chan AT; Kirkner GJ; Mino-Kenudson M; Fuchs CS; Ogino S
    BMC Cancer; 2008 Jan; 8():33. PubMed ID: 18230181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
    García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
    Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent p53 gene mutations in serrated adenomas of the colorectum.
    Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
    J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Screening for the Serrated Pathway.
    Anderson JC; Srivastava A
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):457-478. PubMed ID: 32439082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
    Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.
    Caruso M; Moore J; Goodall GJ; Thomas M; Phillis S; Tyskin A; Cheetham G; Lerda N; Takahashi H; Ruszkiewicz A
    Virchows Arch; 2009 Mar; 454(3):291-302. PubMed ID: 19172291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
    Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
    J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colorectal serrated adenoma: diagnostic criteria and clinical implications].
    Rüschoff J; Aust D; Hartmann A
    Verh Dtsch Ges Pathol; 2007; 91():119-25. PubMed ID: 18314605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and molecular characteristics of hyperplastic polyposis.
    Rashid A; Houlihan PS; Booker S; Petersen GM; Giardiello FM; Hamilton SR
    Gastroenterology; 2000 Aug; 119(2):323-32. PubMed ID: 10930367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
    Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
    Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways.
    Jass JR; Biden KG; Cummings MC; Simms LA; Walsh M; Schoch E; Meltzer SJ; Wright C; Searle J; Young J; Leggett BA
    J Clin Pathol; 1999 Jun; 52(6):455-60. PubMed ID: 10562815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.